- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Sona Nanotech Inc: Sona Nanotech sees 80% response in cancer study | 1 | Stockwatch | ||
| Mo | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 264 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| Sa | Sona Nanotech Inc: Sona Nanotech to host investor webinar Oct. 20 | 1 | Stockwatch | ||
| Fr | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 741 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 26.08. | Sona Nanotech Inc: Sona completes treatment of first patient cohort in FS | 3 | Stockwatch | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 25.08. | Sona Nanotech advances cancer therapy with promising early results | 1 | The Market Herald Canada | ||
| 25.08. | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 675 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 23.07. | Sona Nanotech Inc: Sona receives ethics board OK for THT pilot human study | 1 | Stockwatch | ||
| 23.07. | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 604 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 08.07. | Sona Nanotech doses first patient in groundbreaking cancer therapy trial | 1 | The Market Herald Canada | ||
| 08.07. | Sona Nanotech Inc: Sona completes first dosing in early FS trial | 1 | Stockwatch | ||
| 07.07. | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 802 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06. | Sona Nanotech Inc: Sona receives committee approval for melanoma trial | 2 | Stockwatch | ||
| 27.06. | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 566 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 17.06. | Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia | 7 | Stockwatch | ||
| 16.06. | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 508 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
| 28.05. | Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods | 14 | Stockwatch | ||
| 27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 688 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
| 16.05. | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 4 | Stockwatch | ||
| 15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 973 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 24,350 | +2,53 % | EQS-News: Formycon AG: Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien und Lateinamerika | EQS-News: Formycon AG
/ Schlagwort(e): Vereinbarung
Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien... ► Artikel lesen | |
| OBDUCAT | 0,035 | 0,00 % | NGM MARKET NOTICE: #25-43 Information regarding the last day of trading in paid subscribed shares issued by Obducat AB | ||
| SOLESENCE | 3,790 | -3,56 % | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
| ONTO INNOVATION | 117,00 | 0,00 % | Onto Innovation stock price target raised by Oppenheimer to $180 | ||
| GAUZY | 6,420 | +1,10 % | Gauzy Ltd. Announces Second Quarter 2025 Results | Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated... ► Artikel lesen | |
| KOPIN | 3,440 | -2,49 % | Stifel resumes Kopin stock coverage with Buy rating on DoD contracts | ||
| NVE | 62,50 | -0,79 % | Dividendenbekanntmachungen (04.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIPRISE FINANCIAL INC US03076C1062 1,6 USD 1,3806 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0258 EUR ATLANTIC UNION... ► Artikel lesen | |
| GOMSPACE | 1,582 | -2,22 % | GomSpace Group AB: GomSpace announces upgraded 2025 outlook with substantial revenue growth and strong EBITDA margin | GomSpace increases its revenue outlook by more than 100 M.SEK and confirms a strong positive EBITDA margin.
Revenue: 420 to 450 M.SEK (320 to 380 M.SEK)
EBITDA margin: 6% to 12% (-2% to +10%)
EBITDA... ► Artikel lesen | |
| NANOVIRICIDES | 1,260 | -3,82 % | A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus | SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,408 | +5,70 % | Fendx Technologies Inc (2): Fendx renews IR services agreement with OTB | ||
| ZENTEK | 0,730 | +0,69 % | Zentek Ltd.: Zentek Announces Upsizing of Non-Brokered Private Placement to up to $2,500,000 | Guelph, Ontario--(Newsfile Corp. - October 20, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased... ► Artikel lesen | |
| VEECO INSTRUMENTS | 25,200 | 0,00 % | Veeco Instruments Inc.: Veeco Receives Multiple Lumina Systems Order from Leading Optical Communications Laser Manufacturer | ||
| ACACIA RESEARCH | 2,940 | +1,38 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie | ||
| ADVANCE ZINCTEK | 0,474 | 0,00 % | ADVANCE ZINCTEK LIMITED: Notice of Annual General Meeting/Proxy Form | ||
| LAMPETIA | 0,102 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.